Martina Marrali

Immunology and Microbiology · Life Sciences

4h-index346citations13works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(7), Liver physiology and pathology(5), SARS-CoV-2 and COVID-19 Research(4), RNA Interference and Gene Delivery(3), Cancer Immunotherapy and Biomarkers(2)

Publications13 total

P-100. Durable immune response induced by self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidates against variants of concern (VOC) in HIV-negative and people living with HIV (PLWH) populations in South Africa, irrespective of prior SARS-CoV-2 vaccination
Open Forum Infectious Diseases·2025Open Access
2372. Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population
Open Forum Infectious Diseases·2023· 1 citedOpen Access
2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series
Open Forum Infectious Diseases·2023Open Access
GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults
Nature Communications·2023· 37 citedOpen Access
Abstract 2267: HLA-DR-restricted CD4 T cell responses to KRAS G12C in healthy donors linked to bacterial mimotope: lessons for KRAS neoantigen vaccines in cancer patients
Cancer Research·2023
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
Nature Medicine·2022· 206 citedOpen Access
Abstract 3578: Optimization of shared neoantigen vaccine design to increase vaccine potency: From bench to bedside and back
Cancer Research·2022· 1 cited
Abstract 4159: Lower doses of self-amplifying mRNA drive superior neoantigen-specific CD8 T cell responses in cancer patients versus high doses
Cancer Research·2022· 1 cited
Cirrhotic extracellular matrix affects Hic-5 expression in primary human hepatic stellate cells
Journal of Hepatology·2020Open Access
Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition
Cells·2019· 73 citedOpen Access
SAT-397-HIC-5 and GARP expression is upregulated by hydrogen peroxide and TGF beta in primary human hepatic stellate cells cultured on decellularized human liver 3D ECM scaffolds
Journal of Hepatology·2019
The adenosine monophosphate–activated protein kinase—vacuolar adenosine triphosphatase–pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells
Hepatology·2018· 27 cited
Aspecific ECM composition regulates Smad dependent – TGFbeta1-induced EMT response in HepG2 cells engineered in cirrhotic and healthyliver 3D scaffolds
Journal of Hepatology·2018

Frequent Co-authors

Meghan G. Hart(8), Karin Jooss(8), Christine D. Palmer(7), Sonia Kounlavouth(7), Amy Rappaport(5), Jason R. Jaroslavsky(5), Massimo Pinzani(5), Krista Rombouts(5), Harshni Venkatraman(5), Ciaran D. Scallan(4), Leonid Gitlin(4), Lauren D. Kraemer(4), Charmaine N. Nganje(4), Giuseppe Mazza(4), Walid Al‐Akkad(4), Luca Frenguelli(4), Raphaël F. Rousseau(3), Daniel V.T. Catenacci(3), Kessarin Thanapirom(3), Maria Giovanna Vilia(3)